Johnson and Johnson considers 20 billion dollar sale of its orthopedics business
Johnson and Johnson is exploring a potential sale of its DePuy Synthes orthopedics unit for over 20 billion dollars. Major buyout firms are showing interest.
Insights:
Johnson & Johnson is preparing a potential sale of its DePuy Synthes orthopedics unit, according to reports on February 19, 2026. Bloomberg News reported that the unit could be valued at more than $20 billion and that big buyout firms are already circling the business. The company has been planning to separate the DePuy Synthes unit, and a sale at this scale would be a major corporate divestiture with significant financial and ownership implications for Johnson & Johnson.
